Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-31

FDA Approved: VOQUEZNA TRIPLE PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Voquezna Triple Pak (vonoprazan fumarate, amoxicillin and clarithromycin) from Phathom Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOQUEZNA TRIPLE PAK (VONOPRAZAN FUMARATE, AMOXICILLIN AND CLARITHROMYCIN)

Snippet

SUPPL AP for VOQUEZNA TRIPLE PAK (VONOPRAZAN FUMARATE, AMOXICILLIN AND CLARITHROMYCIN)